News
Researchers who conducted a real-world analysis of trastuzumab deruxtecan found the drug to be effective in treating metastatic breast cancer, though survival outcomes did not reach clinical trial ...
AstraZeneca, in collaboration with Daiichi Sankyo, is conducting a Phase 2 study titled DESTINY-PanTumor02 to evaluate the efficacy and safety of Trastuzumab Deruxtecan (T-DXd) in treating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback